• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Avadel Pharma says its sleep disorder drug remains under FDA review

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 12, 2024 at 10:42: AM
via Avadel Pharmaceuticals' (AVDL.O), opens new tab sleep disorder drug for use in pediatric patients seven years and older remains under review by the U.S. Food and Drug Administration, the company said in a regulatory filing on Thursday.

article source
 




Top Bottom
Back
Quote